WEBINAR
Bridging AS Patient Identification with Clinical Action
A peer-to-peer conversation on how Nebraska Methodist achieved outstanding results in the American Heart Association’s Target: Aortic Stenosis program
Leading structural heart programs succeed by identifying the right patients at scale and efficiently guiding them through evaluation, treatment, and follow-up. The CardioCare® Platform* helps bring these capabilities together, providing visibility across the patient population and supporting coordinated clinical workflows.
Watch the webinar recording below.
Key Insights from Cindy Valgora
How Nebraska Methodist Uses egnite CardioCare® to Speed Structural Heart Referrals
Untreated and undertreated aortic stenosis (AS) patients often get missed or lost to follow-up. The platform helps surface those patients, bring them back into care, and create a more consistent, trackable path from identification to referral.
CardioCare® Flags Severe AS Patient—Accelerating Evaluation to TAVR
Extra weeks in the referral process can increase risk—symptom progression, potential hospitalization, and patients leaving for other systems. Proactive identification and streamlined routing help keep patients on track, in-network, and treated before deterioration occurs.
Making the Case for TAVR Resources with CardioCare®
Nebraska Methodist tracked TAVR growth beyond its 20% target (to ~35%) and used that visibility to justify added support—staffing, equipment, and additional OR time—by demonstrating workload with data, not anecdotes.
Using CardioCare® to Show National-Goal Performance
Program data met American Heart Association benchmarks for timely diagnosis and care, supporting clinician alignment. Strong results led to a five-year continuation in the AHA study with annual grant support, tracking untreated and moderate AS.
CARDIOCARE RESOURCES
See What Leading Cardiovascular Programs Are Doing
Built as an end-to-end solution, the CardioCare Platform supports cardiovascular teams by automatically identifying eligible patients and managing them from diagnosis through treatment—reducing manual chart review and improving care coordination.
The CardioCare platform is not intended for use in the diagnosis, cure, mitigation, treatment or prevention of cardiovascular diseases.
© 2026 egnite, Inc. All Rights Reserved. egnite, egnite Inc., CardioCare, the heart logo, and the spark logo are trademarks of egnite, Inc. All other trademarks are property of their respective owners.
Privacy Policy Intellectual Property Terms of Use Implementation Kit Careers